Evotec (EVO)
(Delayed Data from NSDQ)
$5.02 USD
-0.08 (-1.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.00 -0.02 (-0.40%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Evotec AG [EVO]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: Evotec AG
Industry: Medical - Drugs
Optimized Entry and Exit Levels for EVO 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Evotec AG
Industry: Medical - Drugs
Evotec Emerges Stronger Following Cyberattack; PT Up to $14; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Evotec Reaps Rewards from Collaboration with Bristol Myers Squibb
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Evotec''s Advances in Drug Discovery, Development and Manufacturing; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Evotec AG
Industry: Medical - Drugs
Company: Evotec AG
Industry: Medical - Drugs
Stepping on the Accelerator of Drug Development; Initiate at Buy With $12 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|